LOX-1, OxLDL, and atherosclerosis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Pirillo, Angela ^a,b   Norata, Giuseppe Danilo ^a,c,d   Catapano, Alberico Luigi ^b,c  

^a Bassini Hospital   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; C REACTIVE PROTEIN; CASPASE 3; CASPASE 9; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; OCTAMER TRANSCRIPTION FACTOR 1; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; LIGAND; LOW DENSITY LIPOPROTEIN; OLR1 PROTEIN, HUMAN;

ACUTE HEART INFARCTION; APOPTOSIS; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; BONE MARROW CELL; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; COMMON CAROTID ARTERY; DNA DAMAGE; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FOAM CELL; HEART INFARCTION; HOMEOSTASIS; HUMAN; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SHEAR STRESS; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULITIS; VASODILATATION; ANIMAL; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LIGANDS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, SMOOTH MUSCLE; PLATELET ACTIVATION; REPERFUSION INJURY; SCAVENGER RECEPTORS, CLASS E;

EID: 84880839097     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/152786     Document Type: Review

References (97)

1. Libby P., Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 9 2045 2051 10.1161/ATVBAHA.108.179705
2. Hansson G. K., Robertson A. K., Soderberg-Naucler C., Inflammation and atherosclerosis. Annual Review of Pathology 2006 1 297 329 10.1146/annurev. pathol.1.110304.100100
3. Levitan I., Volkov S., Subbaiah P. V., Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxidants and Redox Signaling 2010 13 1 39 75 2-s2.0-77952966112 10.1089/ars.2009.2733
4. Dunn S., Vohra R. S., Murphy J. E., Homer-Vanniasinkam S., Walker J. H., Ponnambalam S., The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochemical Journal 2008 409 2 349 355 2-s2.0-38749118269 10.1042/BJ20071196 (Pubitemid 351184953)
5. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T., An endothelial receptor for oxidized low-density lipoprotein. Nature 1997 386 6620 73 77 2-s2.0-0030941113 10.1038/386073a0 (Pubitemid 27130922)
6. Draude G., Hrboticky N., Lorenz R. L., The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochemical Pharmacology 1999 57 4 383 386 2-s2.0-0032946280 10.1016/S0006-2952(98)00313-X (Pubitemid 29065286)
7. Mehta J. L., Chen J., Hermonat P. L., Romeo F., Novelli G., Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovascular Research 2006 69 1 36 45 2-s2.0-29144488035 10.1016/j.cardiores.2005.09.006 (Pubitemid 41814809)
8. Xu S., Ogura S., Chen J., Little P. J., Moss J., Liu P., LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cellular and Molecular Life Sciences 2012 10.1007/s00018-012-1194-z
9. Pirillo A., Reduzzi A., Ferri N., Kuhn H., Corsini A., Catapano A. L., Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells. Atherosclerosis 2011 214 2 331 337 2-s2.0-79151474344 10.1016/j.atherosclerosis.2010.11.006
10. Pirillo A., Uboldi P., Ferri N., Corsini A., Kuhn H., Catapano A. L., Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins. Biochemical and Biophysical Research Communications 2012 428 2 230 233 10.1016/j.bbrc.2012.10.020
11. Kataoka H., Kume N., Miyamoto S., Minami M., Moriwaki H., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T., Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999 99 24 3110 3117 2-s2.0-0033594968 (Pubitemid 29289075)
12. Mehta J. L., Sanada N., Hu C. P., Chen J., Dandapat A., Sugawara F., Satoh H., Inoue K., Kawase Y., Jishage K.-I., Suzuki H., Takeya M., Schnackenberg L., Beger R., Hermonat P. L., Thomas M., Sawamura T., Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circulation Research 2007 100 11 1634 1642 2-s2.0-34250190986 10.1161/CIRCRESAHA.107.149724 (Pubitemid 46897266)
13. Inoue K., Arai Y., Kurihara H., Kita T., Sawamura T., Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circulation Research 2005 97 2 176 184 2-s2.0-22744458273 10.1161/01.RES.0000174286.73200.d4 (Pubitemid 41033474)
14. Twigg M. W., Freestone K., Homer-Vanniasinkam S., Ponnambalam S., The LOX-1 scavenger receptor and its implications in the treatment of vascular disease. Cardiology Research and Practice 2012 2012 6 2-s2.0-84858191495 10.1155/2012/632408 632408
15. Matarazzo S., Quitadamo M. C., Mango R., Ciccone S., Novelli G., Biocca S., Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption. Molecular Pharmacology 2012 82 2 246 254 10.1124/mol.112.078915
16. Mehta J. L., Li D. Y., Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochemical and Biophysical Research Communications 1998 248 3 511 514 2-s2.0-0032581338 10.1006/bbrc.1998.9004 (Pubitemid 28404451)
17. Li D., Mehta J. L., Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 4 1116 1122 2-s2.0-0034118056 (Pubitemid 30207591)
18. Li D., Mehta J. L., Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000 101 25 2889 2895 2-s2.0-0034720846 (Pubitemid 30415877)
19. Mattaliano M. D., Huard C., Cao W., Hill A. A., Zhong W., Martinez R. V., Harnish D. C., Paulsen J. E., Shih H. H., LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. American Journal of Physiology 2009 296 6 C1329 C1337 2-s2.0-66749131891 10.1152/ajpcell.00513.2008
20. Li D., Chen H., Romeo F., Sawamura T., Saldeen T., Mehta J. L., Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. Journal of Pharmacology and Experimental Therapeutics 2002 302 2 601 605 2-s2.0-0036076620 10.1124/jpet.102.034959 (Pubitemid 34787225)
21. Zhu H., Xia M., Hou M., Tang Z., Li Y., Ma J., Ling W., Ox-LDL plays dual effect in modulating expression of inflammatory molecles through LOX-1 pathway in human umbilical vein endothelial cells. Frontiers in Bioscience 2005 10 2 2585 2594 2-s2.0-21344473678 (Pubitemid 40905262)
22. Lawrence T., The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology 2009 1 6 a001651 2-s2.0-77955906264 10.1101/cshperspect.a001651
23. Cominacini L., Fratta Pasini A., Garbin U., Davoli A., Tosetti M. L., Campagnola M., Rigoni A., Pastorino A. M., Lo Cascio V., Sawamura T., Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF- B through an increased production of intracellular reactive oxygen species. Journal of Biological Chemistry 2000 275 17 12633 12638 2-s2.0-0034724687 10.1074/jbc.275.17.12633 (Pubitemid 30241412)
24. Lievens D., Eijgelaar W. J., Biessen E. A. L., Daemen M. J. A. P., Lutgens E., The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thrombosis and Haemostasis 2009 102 2 206 214 2-s2.0-70350447306 10.1160/TH09-01-0029
25. Li D., Liu L., Chen H., Sawamura T., Mehta J. L., LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 816 821 2-s2.0-0038301121 10.1161/01.ATV.0000066685.13434.FA (Pubitemid 36566171)
26. Förstermann U., Sessa W. C., Nitric oxide synthases: regulation and function. European Heart Journal 2012 33 7 829 837 2-s2.0-84859487532 10.1093/eurheartj/ehr304
27. Blair A., Shaul P. W., Yuhanna I. S., Conrad P. A., Smart E. J., Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. Journal of Biological Chemistry 1999 274 45 32512 32519 2-s2.0-0033527664 10.1074/jbc.274.45.32512 (Pubitemid 29523002)
28. Cominacini L., Rigoni A., Pasini A. F., Garbin U., Davoli A., Campagnola M., Pastorino A. M., Lo Cascio V., Sawamura T., The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. Journal of Biological Chemistry 2001 276 17 13750 13755 2-s2.0-0035958019
29. Ryoo S., Lemmon C. A., Soucy K. G., Gupta G., White A. R., Nyhan D., Shoukas A., Romer L. H., Berkowitz D. E., Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circulation Research 2006 99 9 951 960 2-s2.0-33750491292 10.1161/01.RES.0000247034.24662.b4 (Pubitemid 44657798)
30. Ryoo S., Bhunia A., Chang F., Shoukas A., Berkowitz D. E., Romer L. H., OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 2011 214 2 279 287 2-s2.0-79151475294 10.1016/j.atherosclerosis.2010.10.044
31. Xu X., Gao X., Potter B. J., Cao J.-M., Zhang C., Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 871 877 2-s2.0-34247228765 10.1161/01.ATV.0000259358.31234.37 (Pubitemid 46606719)
32. Pernow J., Shemyakin A., Böhm F., New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sciences 2012 91 13-14 507 516 2-s2.0-84860157496 10.1016/j.lfs.2012.03.029
33. Sakurai K., Cominacini L., Garbin U., Pasini A. F., Sasaki N., Takuwa Y., Masaki T., Sawamura T., Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1). Journal of Cardiovascular Pharmacology 2004 44 supplement 1 S173 S180 2-s2.0-11144275336 10.1097/01.fjc.0000166243.43616.8b (Pubitemid 40039671)
34. Montecucco F., Pende A., Mach F., The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. Mediators of Inflammation 2009 2009 13 2-s2.0-65749094793 10.1155/2009/752406 752406
35. Morawietz H., Rueckschloss U., Niemann B., Duerrschmidt N., Galle J., Hakim K., Zerkowski H.-R., Sawamura T., Holtz J., Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 1999 100 9 899 902 2-s2.0-0033621112 (Pubitemid 29407168)
36. Li D., Singh R. M., Liu L., Chen H., Singh B. M., Kazzaz N., Mehta J. L., Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovascular Research 2003 57 1 238 243 2-s2.0-0037215751 10.1016/S0008-6363(02)00674-0 (Pubitemid 36009456)
37. Salvayre R., Auge N., Benoist H., Negre-Salvayre A., Oxidized low-density lipoprotein-induced apoptosis. Biochimica et Biophysica Acta 2002 1585 2-3 213 221 2-s2.0-0037203321 10.1016/S1388-1981(02)00343-8 (Pubitemid 36092085)
38. Chen J., Mehta J. L., Haider N., Zhang X., Narula J., Li D., Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circulation Research 2004 94 3 370 376 2-s2.0-1242297561 10.1161/01.RES.0000113782.07824.BE (Pubitemid 38240729)
39. Imanishi T., Hano T., Sawamura T., Takarada S., Nishio I., Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Circulation Journal 2002 66 11 1060 1064 2-s2.0-0036859245 10.1253/circj.66.1060 (Pubitemid 35416346)
40. Chen X.-P., Xun K.-L., Wu Q., Zhang T.-T., Shi J.-S., Du G.-H., Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascular Pharmacology 2007 47 1 1 9 2-s2.0-34249696430 10.1016/j.vph.2007.01.004 (Pubitemid 46830770)
41. Rueckschloss U., Galle J., Holtz J., Zerkowski H.-R., Morawietz H., Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 2001 104 15 1767 1772 2-s2.0-0035834028 (Pubitemid 32963340)
42. Ou H.-C., Song T.-Y., Yeh Y.-C., Huang C.-Y., Yang S.-F., Chiu T.-H., Tsai K.-L., Chen K.-L., Wu Y.-J., Tsai C.-S., Chang L.-Y., Kuo W.-W., Lee S.-D., EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. Journal of Applied Physiology 2010 108 6 1745 1756 2-s2.0-77953158972 10.1152/japplphysiol.00879.2009
43. Shi Y., Cosentino F., Camici G. G., Akhmedov A., Vanhoutte P. M., Tanner F. C., Lüscher T. F., Oxidized low-density lipoprotein activates p66shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase c- β and c-jun n-terminal kinase kinase in human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 9 2090 2097 2-s2.0-80052175705 10.1161/ATVBAHA.111.229260
44. Thum T., Borlak J., LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. Journal of Biological Chemistry 2008 283 28 19456 19464 2-s2.0-50349084747 10.1074/jbc.M708309200
45. Chen J., Liu Y., Liu H., Hermonat P. L., Mehta J. L., Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Biochemical Journal 2006 393 part 1 255 265 2-s2.0-30044441165 10.1042/BJ20050845 (Pubitemid 43049322)
46. Liu P., Sun M., Sader S., Matrix metalloproteinases in cardiovascular disease. The Canadian Journal of Cardiology 2006 22 supplement B 25B 30B (Pubitemid 44963568)
47. Li D., Liu L., Chen H., Sawamura T., Ranganathan S., Mehta J. L., LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003 107 4 612 617 2-s2.0-0037418043 10.1161/01.CIR.0000047276.52039.FB (Pubitemid 36176813)
48. Li L., Renier G., The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis 2009 204 1 40 46 2-s2.0-67349263070 10.1016/j.atherosclerosis.2008.08.008
49. Dandapat A., Hu C., Sun L., Mehta J. L., Small concentrations of OXLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 11 2435 2442 2-s2.0-36049027675 10.1161/ATVBAHA.107.152272 (Pubitemid 350203961)
50. Diebold I., Kraicun D., Bonello S., Görlach A., The 'PAI-1 paradox' in vascular remodelling. Thrombosis and Haemostasis 2008 100 6 984 991 2-s2.0-57349085013 10.1160/TH08-08-0524
51. Sangle G. V., Zhao R., Shen G. X., Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells. American Journal of Physiology 2008 295 5 E1243 E1254 2-s2.0-57049102872 10.1152/ajpendo.90415.2008
52. Hu B., Li D., Sawamura T., Mehta J. L., Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells. Biochemical and Biophysical Research Communications 2003 307 4 1008 1012 2-s2.0-0038105318 10.1016/S0006-291X(03)01295-6 (Pubitemid 36871673)
53. Du F., Zhou J., Gong R., Huang X., Pansuria M., Virtue A., Li X., Wang H., Yang X.-F., Endothelial progenitor cells in atherosclerosis. Frontiers in Bioscience 2011 17 6 2327 2349 2-s2.0-84860313181 10.2741/4055
54. Imanishi T., Hano T., Sawamura T., Nishio I., Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clinical and Experimental Pharmacology and Physiology 2004 31 7 407 413 2-s2.0-3843063565 10.1111/j.1440-1681.2004.04022.x (Pubitemid 39044118)
55. Imanishi T., Hano T., Matsuo Y., Nishio I., Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clinical and Experimental Pharmacology and Physiology 2003 30 9 665 670 2-s2.0-0141484398 10.1046/j.1440-1681.2003.03894.x (Pubitemid 37222744)
56. Wang X., Chen J., Tao Q., Zhu J., Shang Y., Effects of ox-LDL on number and activity of circulating endothelial progenitor cells. Drug and Chemical Toxicology 2004 27 3 243 255 2-s2.0-4544371701 10.1081/DCT-120037505 (Pubitemid 39238076)
57. Feng X. M., Zhou B., Chen Z., Ren Q., Shi H. L., Sawamura T., Zhong C. H., Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. Journal of Lipid Research 2006 47 6 1227 1237 2-s2.0-33744807726 10.1194/jlr.M500507-JLR200 (Pubitemid 43830715)
58. Sun Y., Chen X., Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species. Fundamental and Clinical Pharmacology 2011 25 5 572 579 2-s2.0-80052901862 10.1111/j.1472-8206.2010. 00885.x
59. Limor R., Kaplan M., Sawamura T., Sharon O., Keidar S., Weisinger G., Knoll E., Naidich M., Stern N., Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway. American Journal of Hypertension 2005 18 3 299 307 2-s2.0-15744388936 10.1016/j.amjhyper.2004.09.008 (Pubitemid 40409908)
60. Chen K.-C., Hsieh I.-C., Hsi E., Wang Y.-S., Dai C.-Y., Chou W.-W., Juo S.-H. H., Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. Journal of Cell Science 2011 124 23 4115 4124 2-s2.0-84856932323 10.1242/jcs.092767
61. Eto H., Miyata M., Kume N., Minami M., Itabe H., Orihara K., Hamasaki S., Biro S., Otsuji Y., Kita T., Tei C., Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochemical and Biophysical Research Communications 2006 341 2 591 598 2-s2.0-31444445203 10.1016/j.bbrc.2005.12.211 (Pubitemid 43152144)
62. Kataoka H., Kume N., Miyamoto S., Minami M., Morimoto M., Hayashida K., Hashimoto N., Kita T., Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 6 955 960 2-s2.0-0035716605 (Pubitemid 34168652)
63. Aoyama T., Chen M., Fujiwara H., Masaki T., Sawamura T., LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Letters 2000 467 2-3 217 220 2-s2.0-0033953940 10.1016/S0014-5793(00)01154-6 (Pubitemid 30081737)
64. Caplice N. M., Bunch T. J., Stalboerger P. G., Wang S., Simper D., Miller D. V., Russell S. J., Litzow M. R., Edwards W. D., Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4754 4759 2-s2.0-0344713657 10.1073/pnas.0730743100 (Pubitemid 36457802)
65. Yu J., Li Y., Li M., Qu Z., Ruan Q., Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro. International Journal of Experimental Pathology 2010 91 1 24 33 2-s2.0-74549204450 10.1111/j.1365-2613. 2009.00693.x
66. Yoshida H., Kondratenko N., Green S., Steinberg D., Quehenberger O., Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochemical Journal 1998 334 part 1 9 13 2-s2.0-0032528913 (Pubitemid 28420964)
67. Schaeffer D. F., Riazy M., Parhar K. S., LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. Journal of Lipid Research 2009 50 8 1676 1684 10.1194/jlr.M900167- JLR200
68. Perrin-Cocon L., Coutant F., Agaugué S., Deforges S., André P., Lotteau V., Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. Journal of Immunology 2001 167 7 3785 3891 2-s2.0-0035478504 (Pubitemid 32916054)
69. Nickel T., Pfeiler S., Summo C., oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21. Mediators of Inflammation 2012 2012 10 10.1155/2012/320953 320953
70. Nickel T., Schmauss D., Hanssen H., Sicic Z., Krebs B., Jankl S., Summo C., Fraunberger P., Walli A. K., Pfeiler S., Weis M., oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 2009 205 2 442 450 2-s2.0-67650905114 10.1016/j.atherosclerosis.2009.01.002
71. Chen M., Kakutani M., Naruko T., Ueda M., Narumiya S., Masaki T., Sawamura T., Activation-dependent surface expression of LOX-1 in human platelets. Biochemical and Biophysical Research Communications 2001 282 1 153 158 2-s2.0-0034813624 10.1006/bbrc.2001.4516 (Pubitemid 32924358)
72. Daub K., Seizer P., Stellos K., Krämer B. F., Bigalke B., Schaller M., Fateh-Moghadam S., Gawaz M., Lindemann S., Oxidized LDL-activated platelets induce vascular inflammation. Seminars in Thrombosis and Hemostasis 2010 36 2 146 156 2-s2.0-77951550478 10.1055/s-0030-1251498
73. Kakutani M., Masaki T., Sawamura T., A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proceedings of the National Academy of Sciences of the United States of America 2000 97 1 360 364 2-s2.0-0034602694 (Pubitemid 30055836)
74. Cominacini L., Fratta Pasini A., Garbin U., Pastorino A., Rigoni A., Nava C., Davoli A., Lo Cascio V., Sawamura T., The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. Journal of the American College of Cardiology 2003 41 3 499 507 2-s2.0-0037419860 10.1016/S0735-1097(02)02811-5 (Pubitemid 36164510)
75. Kuge Y., Kume N., Ishino S., Takai N., Ogawa Y., Mukai T., Minami M., Shiomi M., Saji H., Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biological and Pharmaceutical Bulletin 2008 31 8 1475 1482 2-s2.0-48849090195 10.1248/bpb.31.1475
76. Ishino S., Mukai T., Kuge Y., Kume N., Ogawa M., Takai N., Kamihashi J., Shiomi M., Minami M., Kita T., Saji H., Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. Journal of Nuclear Medicine 2008 49 10 1677 1685 2-s2.0-53749092641 10.2967/jnumed.107.049536
77. Wang X., Phillips M. I., Mehta J. L., LOX-1 and angiotensin receptors, and their interplay. Cardiovascular Drugs and Therapy 2011 25 5 401 417 2-s2.0-83055194537 10.1007/s10557-011-6331-7
78. Nagase M., Hirose S., Fujita T., Unique repetitive sequence and unexpected regulation of expression of rat endothelial receptor for oxidized low-density lipoprotein (LOX-1). Biochemical Journal 1998 330 3 1417 1422 2-s2.0-0032521561 (Pubitemid 28162024)
79. Ando K., Fujita T., Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage. Clinical and Experimental Nephrology 2004 8 3 178 182 2-s2.0-7044274552 10.1007/s10157-004- 0288-9 (Pubitemid 39421365)
80. Nagase M., Ando K., Nagase T., Kaname S., Sawamura T., Fujita T., Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium. Biochemical and Biophysical Research Communications 2001 281 3 720 725 2-s2.0-0034806004 10.1006/bbrc.2001.4374 (Pubitemid 32917860)
81. Chen M., Nagase M., Fujita T., Narumiya S., Masaki T., Sawamura T., Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. Biochemical and Biophysical Research Communications 2001 287 4 962 968 2-s2.0-0035812691 10.1006/bbrc.2001.5674 (Pubitemid 32953570)
82. Li D., Williams V., Liu L., Chen H., Sawamura T., Romeo F., Mehta J. L., Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. Journal of the American College of Cardiology 2003 41 6 1048 1055 2-s2.0-0037454162 10.1016/S0735-1097(02)02966-2 (Pubitemid 36315552)
83. Hu C., Dandapat A., Chen J., Fujita Y., Inoue N., Kawase Y., Jishage K.-I., Suzuki H., Sawamura T., Mehta J. L., LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. Cardiovascular Research 2007 76 2 292 302 2-s2.0-36649020178 10.1016/j.cardiores.2007.07.003 (Pubitemid 350198599)
84. Hu C., Chen J., Dandapat A., Fujita Y., Inoue N., Kawase Y., Jishage K.-I., Suzuki H., Li D., Hermonat P. L., Sawamura T., Mehta J. L., LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. Journal of Molecular and Cellular Cardiology 2008 44 1 76 83 2-s2.0-37549046852 10.1016/j.yjmcc.2007.10.009
85. Mango R., Predazzi I. M., Romeo F., Novelli G., LOX-1/LOXIN: the Yin/Yang of atheroscleorosis. Cardiovascular Drugs and Therapy 2011 25 5 489 494 2-s2.0-83055181263 10.1007/s10557-011-6333-5
86. Mango R., Biocca S., del Vecchio F., Clementi F., Sangiuolo F., Amati F., Filareto A., Grelli S., Spitalieri P., Filesi I., Favalli C., Lauro R., Mehta J. L., Romeo F., Novelli G., In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circulation Research 2005 97 2 152 158 2-s2.0-22744450055 10.1161/01.RES. 0000174563.62625.8e (Pubitemid 41033471)
87. Biocca S., Filesi I., Mango R., Maggiore L., Baldini F., Vecchione L., Viola A., Citro G., Federici G., Romeo F., Novelli G., The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. Journal of Molecular and Cellular Cardiology 2008 44 3 561 570 2-s2.0-40649099556 10.1016/j.yjmcc.2007.11.017
88. Biocca S., Falconi M., Filesi I., Baldini F., Vecchione L., Mango R., Romeo F., Federici G., Desideri A., Novelli G., Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS One 2009 4 2, article e4648 2-s2.0-65249101464 10.1371/journal.pone.0004648
89. Mango R., Clementi F., Borgiani P., Forleo G. B., Federici M., Contino G., Giardina E., Garza L., Fahdi I. E., Lauro R., Mehta J. L., Novelli G., Romeo F., Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. Journal of Medical Genetics 2003 40 12 933 936 2-s2.0-9144244821 (Pubitemid 38117545)
90. Ohmori R., Momiyama Y., Nagano M., Taniguchi H., Egashira T., Yonemura A., Nakamura H., Kondo K., Ohsuzu F., An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clinical Cardiology 2004 27 11 641 644 2-s2.0-7444258994 (Pubitemid 39441747)
91. Tatsuguchi M., Furutani M., Hinagata J.-I., Tanaka T., Furutani Y., Imamura S.-I., Kawana M., Masaki T., Kasanuki H., Sawamura T., Matsuoka R., Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochemical and Biophysical Research Communications 2003 303 1 247 250 2-s2.0-0037470788 10.1016/S0006-291X(03)00326-7 (Pubitemid 36338232)
92. Kurnaz Ö., Aydoan H. Y., Isbir C. S., Tekeli A., Isbir T., Is LOX-1 K167N polymorphism protective for coronary artery disease? In Vivo 2009 23 6 969 973 2-s2.0-75149189542
93. Norata G. D., Garlaschelli K., Grigore L., Raselli S., Tramontana S., Meneghetti F., Artali R., Noto D., Cefalù A. B., Buccianti G., Averna M., Catapano A. L., Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles. Atherosclerosis 2010 208 1 177 182 2-s2.0-73449143804 10.1016/j.atherosclerosis.2009.06.023
94. Norata G. D., Raselli S., Grigore L., Garlaschelli K., Vianello D., Bertocco S., Zambon A., Catapano A. L., Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 2009 206 2 556 562 2-s2.0-70349425845 10.1016/j.atherosclerosis.2009.03.017
95. Predazzi I. M., Norata G. D., Vecchione L., Garlaschelli K., Amati F., Grigore L., Cutuli L., Pirillo A., Tramontana S., Romeo F., Novelli G., Catapano A. L., Association between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population. PLoS One 2012 7 2 2-s2.0-84856775548 10.1371/journal.pone.0031086 e31086
96. Wang L., Yanuck D., Beecham A., Gardener H., Slifer S., Blanton S. H., Sacco R. L., Rundek T., A candidate gene study revealed sex-specific association between the OLR1 gene and carotid plaque. Stroke 2011 42 3 588 592 2-s2.0-79952071989 10.1161/STROKEAHA.110.596841
97. Amati F., Diano L., Vecchione L., LOX-1 inhibition in ApoE KO mice using a schizophyllan-based antisense oligonucleotide therapy. Molecular Therapy. Nucleic Acids 2012 1 12, article e58